ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$71.86
+3.07 (+4.46%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-3.3% upside
Low Target
$62.98
Average Target
$69.50
High Target
$88.85
Current Price
$71.86
Current
$71.86
$71.86
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Scenario Analysis
Bear Case
$62.98
-12.4%
Low target
Base Case
$69.50
-3.3%
Avg target
Bull Case
$88.85
+23.6%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$95.49
-24.7% from high
52-Week Low
$29.04
+147.5% from low
50-Day SMA
$66.84
+7.5% vs SMA
200-Day SMA
$36.65
+96.1% vs SMA
RSI (14)
36.5
Neutral
Target vs 52W High
$69.50
-27.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |